• UCB and Praxis Precision Medicines announce epilepsy research collaboration

    Tuesday December 13th 2022

  • Analis takes over Vos Instrumenten

    Tuesday December 13th 2022

  • UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa

    Friday December 9th 2022

  • Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity

    Tuesday December 6th 2022

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022

  • FIT stimulates market diversification with renewed subsidy

    Thursday December 1st 2022

  • Biotalys creates Scientific Advisory Committee with leading experts

    Thursday December 1st 2022

  • argenx enters into agreement to acquire priority review voucher

    Wednesday November 30th 2022

  • Your news here?

  • Monkeys not Donkeys, QbD Group’s life science marketing and communication agency, strengthens its team

    Monday November 28th 2022

  • Ghent start-up Protealis accelerates local soybean development

    Friday November 25th 2022

  • VIB researchers identify a new way of supporting and sensitizing immunotherapy in cancer patients

    Friday November 25th 2022


Strategic Partners